Meta Materials Inc. (MMAT) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired the publicly traded

Natera, Inc. (NTRA) Misstated the Accuracy of its Prenatal Tests On January 1, 2022, an article from the New York Times called into question the accuracy of certain noninvasive prenatal

Reata Pharmaceuticals, Inc. (RETA) Made Material Misstatements Regarding the Viability of its Drug Bardoxolone   A class action was filed on behalf of all persons and entities that purchased or

Talis Biomedical Corporation (TLIS) Issued a Misleading Registration Statement in Connection with its IPO    A shareholder filed a class action on behalf of all persons and entities that purchased

Talkspace, Inc. (TALK) Issued a False and Misleading Proxy in Support of its Merger   A class action was filed on behalf of all holders of Talkspace, Inc. (NASDAQ: TALK,

Hyzon Motors Inc. (HYZN) Misrepresented its Customer List and Production Capabilities    A shareholder filed a class action on behalf of all persons and entities that purchased or otherwise acquired

Clarivate Plc (CLVT) Made Financial Misstatements On December 27, 2021, Clarivate disclosed in a filing with the U.S. Securities and Exchange Commission that “[o]n December 22, 2021, Clarivate .. .

Applied Therapeutics, Inc. (APLT) Holds Submission of New Drug Application for AT-007 Applied Therapeutics Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, Galactosemia, and diabetic complications.

Meta Materials Inc. (MMAT) Misled Investors Regarding its Business Prospects   A shareholder filed a class action on behalf of all persons who purchased or otherwise acquired the publicly traded